AdvanceTEC, the market leader in cleanroom design, prefabrication, modularization, and missioncritical process integration for over 25 years, has been acquired by Equans U.S. Inc.

This strategic acquisition enables AdvanceTEC to expand its capabilities, accelerate innovation, and enhance solution delivery for its customers. It also strengthens Equans’s portfolio in engineering, modular construction, and integrated solutions.

AdvanceTEC’s longstanding commitment to its customers, employees, and technology leadership has solidified it as the first brand in its sector. Now part of Equans, AdvanceTEC is positioned to drive the next generation of cleanroom innovation and growth across the United States.

"Becoming a part of Equans is the exact fit we have been looking for to fulfill the long-term commitment to our employees, our customers, and the brand we’ve worked hard to build over the years,” John Burton, Founder and CEO.

“Our served markets and customers are wanting us to be bigger, to be bolder, and to take on more of their mission critical projects. Being acquired by a strategic partner with global leadership in advanced industrial construction enables us to meet the demands of our valued customers and future demands of our market” Bryan Phelan, President and VP of Sales.

“We are excited to welcome AdvanceTEC into the Equans family. The acquisition marks a key milestone in our U.S. growth strategy. Cleanroom prefabrication and modular capabilities are essential to delivering fast, high-value solutions in mission-critical sectors like biotech,” said Bruno Charrade, Executive Vice President of Equans overseeing the MBU Americas. “AdvanceTEC’s expertise and client relationships strengthen our capabilities and support our vision for growth in high-tech and regulated industries.”

Founded in 2000, AdvanceTEC is the industry leader in designing and constructing cleanrooms through cutting-edge prefabrication and modularization strategies. With a team of over 100 employees, AdvanceTEC serves high-tech sectors including biotechnology, semiconductors, pharmaceuticals, aerospace, and advanced manufacturing.